Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995

Michael S. Gordon, Molly L. Young, Martin S. Tallman, Larry D. Cripe, John M. Bennett, Elisabeth Paietta, Walter Longo, Henry Gerad, Joseph Mazza, Jacob M. Rowe

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995'. Together they form a unique fingerprint.

Medicine & Life Sciences